GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Curative Biosciences CBDX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Curative Biosciences

Its shares trade under the ticker CBDX. It has been listed since 26 August 2004.

Curative Biosciences, Inc. is engaged in the development and marketing of novel therapeutics. The company is headquartered in Miami, Florida. The company went IPO on 2004-08-26. The Company’s product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The firm through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Pharmaceuticals
Listed since
26 Aug 2004
Employees
220

Leadership

Pay as last reported

  • Katherine WestChairwoman of the Board, since 2010$414,835
  • A GrandsaertPresident
  • Richard DamionChief Executive Officer, Director, since 2013
  • William LindbergChief Financial Officer$15,213

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Curative Biosciences Inc possesses several strengths that contribute to its competitive advantage:

Weaknesses

  • Despite its strengths, Curative Biosciences Inc also faces certain weaknesses that could hinder its growth and success:

Opportunities

  • Curative Biosciences Inc can capitalize on the following opportunities to drive growth and expand its market share:

Threats

  • Curative Biosciences Inc must be cautious of the following threats that could negatively impact its business operations:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.